[PDF] Biotechnology In India I eBook

Author : T.K. Ghose
Publisher : Springer
Page : 302 pages
File Size : 39,82 MB
Release : 2003-07-03
Category : Science
ISBN : 3540364889

GET BOOK

The biotechnology business in India with an increase from USD 500 million in 1997 and reaching an estimated USD I billion next year health related prod ucts accounting for 60%, agro and veterinary products together 15%, and con tract R&D, reagents, devices and supplies adding up to the remaining 25% of which the diagnostics share was about 10% of the total surely presented an encouraging picture even five years ago. While volumes have increased, the pat tern has not. According to a report, prepared by McKinsey & Co, India's Phar maceutical industry including domestic and export sales and contract services totals nearly USD 5 billion. Furthermore, the company optimistically projects the growth to a factor of five fold only if both the industry and the government are able to put in place achievable solutions that must take care of the formida ble obstacles preventing further growth. If this assessment is correct, then the established transformation made by IT growth should also provide the confi dence required by the high expectations for biotechnology which have arisen in the country in recent years. Some contributors to this are overenthusiastic these are bureaucrats, some retired scientists and of course the complacent politicians who have the least knowledge of what the new biotechnology is all about. However, there are clear indications of biotechnology growth demon strated by a few but rapidly expanding biotech companies such as Biocon Ltd, Shantha Biotech (P) Lid, Dr.

Author : Tarun K. Ghose
Publisher : Springer
Page : 317 pages
File Size : 50,55 MB
Release : 2003-07-03
Category : Science
ISBN : 3540364668

GET BOOK

The biotechnology business in India with an increase from USD 500 million in 1997 and reaching an estimated USD 1 billion next year health related prod ucts accounting for 60%, agro and veterinary products together 15%, and con tract R&D, reagents, devices and supplies adding up to the remaining 25% of which the diagnostics share was about 10% of the total surely presented an encouraging picture even five years ago. While volumes have increased, the pat tern has not. According to a report, prepared by McKinsey & Co, India's Phar maceutical industry including domestic and export sales and contract services totals nearly USD 5 billion. Furthermore, the company optimistically projects the growth to a factor of five fold only if both the industry and the government are able to put in place achievable solutions that must take care of the formida ble obstacles preventing further growth. If this assessment is correct, then the established transformation made by IT growth should also provide the confi dence required by the high expectations for biotechnology which have arisen in the country in recent years. Some contributors to this are overenthusiastic these are bureaucrats, some retired scientists and of course the complacent politicians who have the least knowledge of what the new biotechnology is all about. However, there are clear indications of biotechnology growth demon strated by a few but rapidly expanding biotech companies such as Biocon Ltd, Shantha Biotech (P) Ltd, Dr.

Author : Vasant P. Gandhi
Publisher : Springer
Page : 288 pages
File Size : 16,70 MB
Release : 2016-07-30
Category : Business & Economics
ISBN : 9811010919

GET BOOK

Biotechnology can bring major breakthroughs in agriculture. The book examines the experience of introduction of biotechnology in Indian agriculture, specifically, examining the performance of Bt cotton versus non-Bt cotton across India’s major cotton states, namely Andhra Pradesh, Gujarat, Maharashtra and Tamil Nadu, which together account for nearly 70 percent of the country’s cotton production. Major advances in biotechnology have made it possible to directly identify genes, determine their functions, and transfer them from one organism to another. The advances have spawned many technologies and Bt cotton is one important outcome. Bt cotton has become one of the most widely cultivated transgenic crops and is currently grown in 21 countries - 11 developing and 10 industrialized countries. The Government of India was relatively late in permitting biotechnology, only approving the cultivation of three transgenic Bt cotton hybrids from April 2002. Many concerns were raised about their performance there was strong opposition from some quarters. In India, Gujarat and Maharastra were the first states to adopt them, followed by Andhra Pradesh, Karnataka, Tamil Nadu and Madhya Pradesh. Based on a sample of 694 farming households, the book examines and analyzes the performance on the yields, pesticide costs, seed costs, overall production costs and profits. It also reports on the environmental impacts, satisfaction with the technology and ways of improving its performance.

Author : T.K. Ghose
Publisher : Springer
Page : 293 pages
File Size : 25,46 MB
Release : 2003-07-18
Category : Science
ISBN : 9783540006091

GET BOOK

The biotechnology business in India with an increase from USD 500 million in 1997 and reaching an estimated USD I billion next year health related prod ucts accounting for 60%, agro and veterinary products together 15%, and con tract R&D, reagents, devices and supplies adding up to the remaining 25% of which the diagnostics share was about 10% of the total surely presented an encouraging picture even five years ago. While volumes have increased, the pat tern has not. According to a report, prepared by McKinsey & Co, India's Phar maceutical industry including domestic and export sales and contract services totals nearly USD 5 billion. Furthermore, the company optimistically projects the growth to a factor of five fold only if both the industry and the government are able to put in place achievable solutions that must take care of the formida ble obstacles preventing further growth. If this assessment is correct, then the established transformation made by IT growth should also provide the confi dence required by the high expectations for biotechnology which have arisen in the country in recent years. Some contributors to this are overenthusiastic these are bureaucrats, some retired scientists and of course the complacent politicians who have the least knowledge of what the new biotechnology is all about. However, there are clear indications of biotechnology growth demon strated by a few but rapidly expanding biotech companies such as Biocon Ltd, Shantha Biotech (P) Lid, Dr.

Author : George John
Publisher : Springer
Page : 0 pages
File Size : 23,16 MB
Release : 2024-08-28
Category : Science
ISBN : 9789819708956

GET BOOK

This book examines the progress in the biotechnology sector in India towards knowledge and innovation driven Bioeconomy. The chapters of the book review different genome editing techniques and the GM crops focusing on the emerging potential in agricultural biotechnology. Chapters on Vaccines and AI in healthcare unfold huge opportunities in medical biotechnology. The book covers the advances in biotechnology towards delivering important benefits of healthcare, particularly through the pharmaceutical industry focusing on new healthcare interventions and delivering innovations. Further, it explores the major opportunities in industrial biotechnology related to bio-pharma, biorefinery, fermentation biotechnology, and growing synergies between industry-academia. Toward the end, the book also reviews the genetic regulation and the critical role of HRD. In summary, the book emphasizes on India as a strong bio-manufacturing hub for innovative, affordable and accessible products for the society and also for global markets while describing the sector wise strategies required.

Author : P Omkar Nadh
Publisher : Taylor & Francis
Page : 173 pages
File Size : 13,26 MB
Release : 2022-06-03
Category : Social Science
ISBN : 1000592251

GET BOOK

This book examines the medical biotechnology industry in India through the lens of a critical political economy. It discusses the sharp trajectory of growth in the biotechnology business and the state of investments, subsidies, and patents which propelled the rise of the industry in India. The book uses in-depth interviews and case studies to analyse the roles of various financial actors, state institutions, and academia in the medical biotechnology ecosystem. Focusing on the relationship between India’s neoliberal policies and the swift growth of the industry, the author examines the merits and demerits of the current market-driven biomedical ecosystem exploring the trends in the industry, biomedical start-ups, the use of human resources, and capital accumulation process. The book reiterates and emphasises the need for the democratisation of scientific and medical work and for striking a balance between economic gains and public health priorities. Comprehensive and insightful, this book will be of interest to scholars and researchers of science technology society studies, public health, economics, business studies, medical sociology, public policy, and political science.